COVID-19 is a respiratory condition caused by a coronavirus. Some people are infected but don’t notice any COVID-19 symptoms (doctors call that being asymptomatic). Most people have mild symptoms and get better on their own. But some have severe problems, such as trouble breathing. The od...
65 million people worldwide are estimated to suffer from long-term symptoms after their SARS-CoV-2 infection (Long COVID). However, there is still little information about the early recovery among those who initially developed Long COVID, i.e. had sympto
“fully vaccinated” was defined as having either two shots of the pfizer or moderna vaccine or one shot of the single dose johnson & johnson vaccine. consider the stats on the relatively high likelihood of developing long covid yet another reason not to intentionally get covid in an effort ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in a variety of clinical symptoms ranging from no or mild to severe disease. Currently, there are multiple postulated mechanisms that may push a moderate to severe disease into a c
Besides respiratory and gastrointestinal symptoms, SARS-CoV-2 also has potential neurotropic effects. Acute hemorrhagic necrotizing encephalopathy is a rare complication of Covid-19. This article presents a case of an 81-yearold female, fully vaccinated, who underwent laparosco...
BMC Infectious Diseases (2024) 24:89 https://doi.org/10.1186/s12879-023-08835-3 BMC Infectious Diseases RESEARCH Open Access Clinical antiviral efficacy of favipiravir in early COVID‑19 (PLATCOV): an open‑label, randomised, controlled, adaptive platform trial Viravarn Luvira1, ...
seven million had died. (WHO2022) The initial reports of high infectivity before symptoms were manifest suggested that the pathogen has some unique characteristics, also evident in the unusual number of long-term complications suffered by a small but significant percentage of COVID-19-infected ...
We aimed to evaluate the safety and virological efficacy of molnupiravir in vaccinated and unvaccinated individuals with COVID-19. Methods This randomised, placebo-controlled, double-blind, phase 2 trial (AGILE CST-2) was done at five National Institute for Health and Care Research sites in ...
Vaccine hesitancy covers a spectrum of intentions, from delaying vaccination to outright refusal to be vaccinated11. Some factors are linked to COVID-19 vaccine hesitancy, with rates in the U.S. highest among three groups: African Americans, women, and conservatives12. Other predictors, including...
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy Article Open access 24 February 2021 Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources Artic...